News
Medical Device Network on MSN
Novocure obtains approval for Optune Lua device in Japan to treat NSCLC
Japan's MHLW has approved Novocure's Optune Lua device alongside PD-1/PD-L1 inhibitors to treat non-small cell lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback